Compounds > 2,5-di-tert-butylhydroquinone

2,5-di-tert-butylhydroquinone and Osteosarcoma

2,5-di-tert-butylhydroquinone has been researched along with Osteosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, CC; Jan, CR; Lin, KL; Lu, T; Lu, YC; Tseng, LL; Wang, JL1
Karin, NJ; Meszaros, JG1

Other Studies

2 other study(ies) available for 2,5-di-tert-butylhydroquinone and Osteosarcoma

ArticleYear
Effect of sertraline on [Ca2+](i) and viability of human MG63 osteosarcoma cells.
    Drug and chemical toxicology, 2013, Volume: 36, Issue:2

    Topics: Apoptosis; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Egtazic Acid; Endoplasmic Reticulum; Estrenes; Humans; Hydroquinones; Mitochondria; Osteosarcoma; Pyrrolidinones; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors; Sertraline; Thapsigargin; Type C Phospholipases

2013
Inhibitors of ER Ca(2+)-ATPase activity deplete the ATP- and thrombin-sensitive Ca2+ pool in UMR 106-01 osteosarcoma cells.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1995, Volume: 10, Issue:5

    Topics: Adenosine Triphosphate; Animals; Antioxidants; Bone Neoplasms; Calcium; Calcium-Transporting ATPases; Cell Membrane; Cell Membrane Permeability; Cytosol; Egtazic Acid; Endoplasmic Reticulum; Fura-2; Hydroquinones; Inositol 1,4,5-Trisphosphate; Nifedipine; Osteoblasts; Osteosarcoma; Terpenes; Thapsigargin; Thrombin; Tumor Cells, Cultured

1995